Wegovy vs Mounjaro vs Zepbound: Why Are the Names So Confusing?

Wegovy.

Mounjaro.

Zepbound.

Ozempic.

If you've been reading about weight loss medications, you may be wondering:

Are these all different drugs?

Or are they basically the same thing with different names?

The answer is...

A little bit of both.

And depending on which country you live in, the names can become even more confusing.

Let's make it simple.

The Simple Brand Name Cheat Sheet

Here's the easiest way to remember it:

Semaglutide

Wegovy → weight management

Ozempic → type 2 diabetes

Tirzepatide

Zepbound → weight management in the U.S.

Mounjaro → type 2 diabetes in the U.S.

In the United States, FDA labeling separates these brands largely by their approved uses. Wegovy contains semaglutide, while Mounjaro and Zepbound both contain tirzepatide.

Simple comparison of Wegovy, Mounjaro, and Zepbound medication boxes on a clean neutral background

Already confused?

Don't worry.

Let's go one by one.

What Is Wegovy?

Wegovy contains semaglutide.

It is used for long-term weight reduction and weight management in eligible people with obesity or certain people with overweight and weight-related health conditions. In the U.S., Wegovy also has additional approved indications in certain patient groups, including cardiovascular risk reduction and treatment of noncirrhotic MASH with moderate-to-advanced liver fibrosis.

And here's an important 2026 update:

Wegovy is no longer only an injection in the United States.

Current FDA prescribing information includes both Wegovy injection and Wegovy tablets. The FDA also approved a higher-dose 7.2 mg Wegovy injection, called Wegovy HD, in March 2026 for certain adults.

So when you read older articles saying:

“Wegovy is a once-weekly injection.”

That information may now be incomplete.

Woman researching Wegovy weight loss medication on a laptop at home

What Is Mounjaro?

Mounjaro contains tirzepatide.

In the United States, Mounjaro is FDA-approved as an addition to diet and exercise to improve blood sugar control in people with type 2 diabetes who meet the labeled age criteria.

But here's why people get confused.

Tirzepatide is also strongly associated with weight loss.

So you may see people online saying:

“I lost weight on Mounjaro.”

That does not mean the U.S. Mounjaro label is specifically a weight-management indication.

In the United States, the tirzepatide brand specifically approved for long-term weight reduction and maintenance is Zepbound.

Same active ingredient.

Different brand name.

Different FDA-labeled use.

So What Is Zepbound?

This is probably the easiest explanation:

Zepbound is tirzepatide branded for weight management in the United States.

The FDA approved Zepbound for long-term weight reduction and maintenance in eligible adults with obesity or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity.

Zepbound also has an FDA-approved indication for moderate-to-severe obstructive sleep apnea in adults with obesity.

So:

Mounjaro = tirzepatide

Zepbound = tirzepatide

The molecule is the same.

But in the United States, the brand names are connected to different approved uses.

Clean side by side concept comparing Mounjaro and Zepbound as two brand names associated with tirzepatide

Why Doesn't Everyone Just Call It Tirzepatide?

Honestly?

That would probably be less confusing.

But medicines often have:

A generic or active ingredient name

and

A brand name

Sometimes the same active ingredient is sold under different brand names for different approved indications.

That's why we have:

Semaglutide → Ozempic and Wegovy

and

Tirzepatide → Mounjaro and Zepbound in the U.S.

The brand name is not just a nickname.

The FDA prescribing information, approved indication, formulation, and instructions need to be checked for the specific product.

Wait... Why Do Europeans Still Say Mounjaro for Weight Loss?

Here's where things get even more confusing.

Medication approvals and brand use can differ by region.

In the European Union, the European Medicines Agency lists Mounjaro for both type 2 diabetes and weight management under specified conditions.

EMA has specifically explained that, in the EU:

Wegovy is authorised for weight management.

Mounjaro is authorised for diabetes and weight management.

So an American may say:

“Zepbound for weight loss.”

While someone in Europe may talk about:

“Mounjaro for weight loss.”

They may both be talking about tirzepatide.

Woman comparing GLP 1 weight loss medication names from the United States and Europe on a laptop

This is exactly why reading health content from different countries can feel so confusing.

Wegovy vs Zepbound: Are They the Same Drug?

No.

This is the biggest thing to remember.

Wegovy contains semaglutide.

Zepbound contains tirzepatide.

Semaglutide is a GLP-1 receptor agonist.

Tirzepatide acts as both a GIP and GLP-1 receptor agonist.

So even though both medications are constantly discussed in weight loss conversations, they are not the same active ingredient.

Don't treat Wegovy, Mounjaro, and Zepbound as interchangeable names.

What About Ozempic?

We can't talk about confusing GLP-1 names without mentioning Ozempic.

Ozempic also contains semaglutide.

But in the U.S. and EU regulatory information, Ozempic is a diabetes medication rather than the semaglutide brand specifically indicated for weight management.

So:

Ozempic and Wegovy share semaglutide.

Just like:

Mounjaro and Zepbound share tirzepatide in the U.S.

That simple comparison makes the names much easier to remember.

The Easiest Way to Remember Everything

Save this:

SEMAGLUTIDE

💉 Ozempic → diabetes

⚖️ Wegovy → weight management

TIRZEPATIDE

💉 Mounjaro → diabetes in the U.S.

⚖️ Zepbound → weight management in the U.S.

EUROPE

🇪🇺 Mounjaro may also be used for approved weight management indications

The exact approved indications can differ by country and can change as regulators approve new uses or formulations.

So Which One Is “The Weight Loss Drug”?

This question is actually too simple.

These are prescription medications with specific indications, warnings, contraindications, and dosing instructions.

Choosing a medication should not be based on:

TikTok.

Celebrity weight loss.

A friend's injection.

Or which drug seems more popular this month.

And the FDA and EMA both treat these as prescription medicines that require appropriate medical use and supervision.

The most useful first step?

Learn the active ingredient.

Semaglutide.

Or tirzepatide.

Once you know that, the confusing brand names suddenly make much more sense.

The Simple GLP-1 Name Rule

Confused by Wegovy, Mounjaro, Zepbound, and Ozempic?

Remember:

Wegovy + Ozempic = semaglutide

Mounjaro + Zepbound = tirzepatide in the U.S.

Then check:

What country are you in?

What is the approved indication?

Which exact product was prescribed?

Because two medications can share an active ingredient...

without being the same branded product or having the same approved use.